Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis

Fig. 1

Time schedule of the treatment of BV and follow-up. a) Group 1, women who did not have BV (“healthy”) receiving probiotic capsules, b) Group 2, women presenting with BV receiving both antibiotics and probiotic capsules, c) Group 3, women presenting with BV receiving antibiotics only. Sociodemographic data and gynaecologic status were filed on visit 0. On visit 1, volunteers were enrolled and given the prescription. Enrolment into each arm was stratified by age-group: 18–29 and 30–40 years, using a blocked randomisation strategy. Microscopic scoring of BV and cultivation of lactobacilli were performed on visit 0, and 2 to 7

Back to article page